Difficulty: Medium
Average Score: 70%
Practice
You are seeing a new older African-American male patient who comes into the office wanting to have his blood pressure checke The patient has a long-standing history of poorly controlled hypertension secondary to not being seen by a provider or obtaining medication. He does not monitor his BP and his reading today is 197/86. Reports he drinks a 12 pack of beer daily. He reports an allergy to ÔÇÿSulfaÔÇÖ drugs breaking out in a miserable rash. You do a urine dip in the office and note it is positive for 1+ glucose and protein. Based on these findings you suspect the patient has undiagnosed diabetes type 2. You order labs and the results come back with a random glucose value of 193, HgbA1C 8.5, a serum creatinine of 1.6 mg/dL (ref range for a male is 0.70 ÔÇô 1.2mg/dL) and elevated LFTs (2-3x above normal range). You negotiate with the patient a medication regimen for both his newly diagnosed diabetes and his long-standing hypertension. Which of the following is the appropriate medication regimen for this patient?
Correct answer
D
Rationale
The appropriate medication regimen for this patient is option D: Victoza and ACE inhibitor.
Victoza, a GLP-1 receptor agonist, is indicated for the treatment of type 2 diabetes. Given the patient's elevated random glucose value and HgbA1C, Victoza can help improve glycemic control. Additionally, it is important to note that the patient has an allergy to sulfa drugs, which eliminates the use of Metformin, a biguanide commonly used in diabetes management.
Furthermore, an ACE inhibitor is the preferred choice for managing hypertension in patients with diabetes, as it provides renal protection and cardiovascular benefits. Considering the patient's elevated serum creatinine level and positive protein in urine, an ACE inhibitor can help slow the progression of diabetic nephropathy and reduce cardiovascular risk.
Option A is incorrect as Metformin is contraindicated due to the patient's sulfa allergy. Option C is also incorrect as Victoza alone is not typically used as initial therapy for diabetes management.
Educationally, this scenario highlights the importance of individualizing medication regimens based on patient-specific factors such as allergies, comorbidities, and lab results. It emphasizes the need for providers to consider both the diabetes and hypertension management in patients with multiple chronic conditions to optimize outcomes and minimize adverse effects.
Victoza, a GLP-1 receptor agonist, is indicated for the treatment of type 2 diabetes. Given the patient's elevated random glucose value and HgbA1C, Victoza can help improve glycemic control. Additionally, it is important to note that the patient has an allergy to sulfa drugs, which eliminates the use of Metformin, a biguanide commonly used in diabetes management.
Furthermore, an ACE inhibitor is the preferred choice for managing hypertension in patients with diabetes, as it provides renal protection and cardiovascular benefits. Considering the patient's elevated serum creatinine level and positive protein in urine, an ACE inhibitor can help slow the progression of diabetic nephropathy and reduce cardiovascular risk.
Option A is incorrect as Metformin is contraindicated due to the patient's sulfa allergy. Option C is also incorrect as Victoza alone is not typically used as initial therapy for diabetes management.
Educationally, this scenario highlights the importance of individualizing medication regimens based on patient-specific factors such as allergies, comorbidities, and lab results. It emphasizes the need for providers to consider both the diabetes and hypertension management in patients with multiple chronic conditions to optimize outcomes and minimize adverse effects.